- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8711
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,711 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
RMDA | ج.م3.58 | 11.2% | 101.1% | ج.م5.4b | ج.م5.02 | PE20.2x | E30.8% | 1.9% | Pharmaceuticals & Biotech | ||
FWRY | ج.م8.50 | 3.2% | 60.4% | ج.م29.0b | ج.م11.39 | PE23.4x | E27.4% | n/a | Diversified Financials | ||
AFISH | NOK 71.00 | -1.4% | 9.2% | NOK 2.3b | NOK 81.00 | PE69.5x | E91.9% | n/a | Food, Beverage & Tobacco | ||
ELABS | NOK 9.13 | -8.3% | -44.4% | NOK 961.2m | NOK 22.00 | PS10.3x | E111.4% | n/a | Software | ||
WAYS | SEK 15.06 | -4.3% | -39.6% | SEK 121.5m | SEK 36.50 | PS1x | E113.3% | 0% | Tech | ||
CADLR | NOK 67.80 | 0.9% | 100.9% | NOK 23.8b | NOK 82.90 | PE223.4x | E69.9% | n/a | Capital Goods | ||
ONON | US$58.33 | -0.2% | 95.5% | US$18.7b | US$58.68 | PE130.5x | E29.6% | n/a | Consumer Durables | ||
ZVRA | US$9.33 | -1.7% | 84.0% | US$498.0m | US$20.00 | PS20.3x | E73.5% | n/a | Pharmaceuticals & Biotech | ||
RHM | €622.40 | 2.2% | 119.6% | €27.0b | €692.87 | PE39.4x | E29.0% | 0.9% | Capital Goods | ||
CRDO | US$48.96 | 4.0% | 155.1% | US$8.1b | US$38.25 | PS37.4x | E95.0% | n/a | Semiconductors | ||
NVG | zł1.66 | -2.4% | -18.6% | zł58.1m | zł3.65 | PS11.9x | E43.5% | 3.6% | Diversified Financials | ||
CCOLA | ₺53.20 | 2.3% | 31.9% | ₺148.9b | ₺85.76 | PE11.6x | E42.0% | 1.3% | Food, Beverage & Tobacco | ||
ICOP | €8.16 | 2.5% | n/a | €225.5m | €9.80 | PE44.6x | E49.2% | n/a | Capital Goods | ||
MVW | NOK 8.95 | -1.1% | 28.2% | NOK 292.8m | NOK 11.70 | PS15.3x | E71.7% | n/a | Materials | ||
ALKT | US$39.47 | -6.5% | 73.1% | US$4.0b | US$44.30 | PS12.6x | E98.6% | n/a | Software | ||
ARES | US$176.73 | 0.4% | 61.5% | US$55.3b | US$174.38 | PE82.5x | E46.3% | 2.1% | Diversified Financials | ||
PHM | €78.10 | 3.3% | 101.3% | €1.4b | €83.20 | PE2202.2x | E56.9% | 0.8% | Pharmaceuticals & Biotech | ||
NEWBRY | SEK 3.44 | -0.6% | -11.8% | SEK 83.4m | SEK 8.00 | PS2.3x | E130.0% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$138.25 | 1.6% | 203.8% | US$3.4t | US$170.44 | PE53.7x | E24.9% | 0.03% | Semiconductors | ||
CDR | zł167.20 | 1.0% | 56.7% | zł16.7b | zł142.33 | PE38x | E28.6% | 0.6% | Media | ||
SKS | AU$2.00 | -2.0% | 733.3% | AU$224.1m | AU$2.15 | PE33.8x | E24.8% | 0.5% | Capital Goods | ||
PRL | CA$38.53 | 3.3% | 221.1% | CA$1.5b | CA$44.28 | PE24.5x | E37.6% | 1.5% | Diversified Financials | ||
GAU | CA$1.98 | -1.5% | 120.0% | CA$509.0m | CA$3.51 | PS2.2x | E89.3% | n/a | Materials | ||
EH | US$15.52 | 1.8% | -11.8% | US$982.2m | US$24.32 | PS20.4x | E81.5% | n/a | Capital Goods |